Financials

  • Market Capitalization 44.5563 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.16
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
6356
ADAP
Adaptimmune Therapeutics plc - American Depositary Shares
0.05 USD0.00%0.00%-61.54%-16.67%0 USD
6359
AADI
Aadi Bioscience Inc
2.05 USD0.00%0.00%-19.29%-27.30%0 USD
6709
NAMSW
NewAmsterdam Pharma Company N.V. - Warrant
16.5100 USD0.00%0.00%-8.28%+22.75%3.09 B USD
6797
DRTSW
Alpha Tau Medical Ltd. - Warrant
3.7900 USD-5.25%-10.10%+53.75%+1387.44%1.29 B USD

Frequently asked questions about Revolution Medicines, Inc. Common Stock

What is the Revolution Medicines, Inc. Common Stock stock price today?

The current price of Revolution Medicines, Inc. Common Stock (RVMDW) is 11.6400. Over the past 24 hours, the stock has changed by -12.22%. Follow the RVMDW chart for real-time price dynamics.

What is the stock ticker of Revolution Medicines, Inc. Common Stock?

Revolution Medicines, Inc. Common Stock trades under the ticker RVMDW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Revolution Medicines, Inc. Common Stock stock going up?

RVMDW has changed by -0.94% over the last week, +33.03% over the last month, and +6895.19% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Revolution Medicines, Inc. Common Stock?

Revolution Medicines, Inc. Common Stock currently has a market capitalization of 44.56 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Revolution Medicines, Inc. Common Stock earnings last quarter?

Last quarter, Revolution Medicines, Inc. Common Stock reported earnings of -3.06 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Revolution Medicines, Inc. Common Stock revenue for the last quarter?

Revolution Medicines, Inc. Common Stock reported quarterly revenue of 1.19 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Revolution Medicines, Inc. Common Stock net income for the last quarter?

Revolution Medicines, Inc. Common Stock reported net income of -644.37 M for the last quarter. The previous quarter showed -453.82 M, which means net income changed by -41.99%.

How many employees does Revolution Medicines, Inc. Common Stock have?

As of the latest available data, Revolution Medicines, Inc. Common Stock has 883 employees. Workforce size can provide additional context about the company's scale and operations.

What is Revolution Medicines, Inc. Common Stock EBITDA?

Revolution Medicines, Inc. Common Stock EBITDA is -505.76 M, and its EBITDA margin is -42.68 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Revolution Medicines, Inc. Common Stock stock?

You can buy Revolution Medicines, Inc. Common Stock (RVMDW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Revolution Medicines, Inc. Common Stock stock?

Investing in Revolution Medicines, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RVMDW chart and related analysis on metatrader.com as part of your research.

News